HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches
0 Görünümler
• 07/03/23
0
0
gömmek
administrator
Aboneler
Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar